EcoDrugPlus

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSMAUG00000019080
Gene Symbol: SYK
4 Cross references
200 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSMAUG00000016735
Gene Symbol: SRD5A2
2 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMAUG00000008590
Gene Symbol: SOAT1
4 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSMAUG00000011416
Gene Symbol: SI
4 Cross references
200 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSMAUG00000018763
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMAUG00000016810
Gene Symbol: TACR1
4 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMAUG00000008248
Gene Symbol: TACR2
4 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMAUG00000004511
Gene Symbol: TACR3
4 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMAUG00000008230
Gene Symbol: TERT
2 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSMAUG00000008938
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSMAUG00000015276
Gene Symbol: TBXA2R
4 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSMAUG00000004074
Gene Symbol: TYMP
3 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).